BridgeBio Pharma EPS Basic from Extraordinaries (Quarterly) Insights

BridgeBio Pharma, Inc. (BBIO)

77.25 +3.43 (+4.65%) USD | NASDAQ | Jan 09, 16:00

77.20 -0.05 (-0.06%) Pre-Market: 09:08

View EPS Basic from Extraordinaries (Quarterly) for BBIO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Extraordinaries (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Extraordinaries (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Extraordinaries (Quarterly) Benchmarks

Start Trial

Pfizer Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Supernus Pharmaceuticals, Inc.	--
Ionis Pharmaceuticals, Inc.	--
Regeneron Pharmaceuticals, Inc.	--